News

• 14 Oct, 2025
  Synligt tumörupptag och rekommenderad doshöjning i Spago Nanomedicals fas I/IIa-studie Tumorad-01
• 14 Oct, 2025
  Visible tumor uptake and recommended dose increase in Spago Nanomedicals’s Phase I/IIa study Tumorad-01
• 20 Aug, 2025
  Spago Nanomedical delårsrapport januari-juni 2025
• 20 Aug, 2025
  Spago Nanomedical interim report January-June, 2025
• 3 Jun, 2025
  Spago Nanomedical continues patient recruitment in the phase I/IIa study Tumorad-01 as planned after DMC recommendation
• 3 Jun, 2025
  Spago Nanomedical fortsätter planenligt patientrekryteringen i fas I/IIa-studien Tumorad-01 efter DMC-rekommendation
• 14 May, 2025
  Bulletin from the 2025 Annual General Meeting of Spago Nanomedical AB
• 14 May, 2025
  Kommuniké från årsstämma 2025 i Spago Nanomedical AB
• 7 May, 2025
  Spago Nanomedical delårsrapport januari-mars 2025
• 7 May, 2025
  Spago Nanomedical interim report January-March, 2025